Get started
Author

Noura Elsedawy

NCCN Guidelines® Insights: Multiple Myeloma, Version 3.2022
2022 · Natalie S. Callander, Muhamed Baljevic, et al. · Journal of the National Comprehensive Cancer Network · 209
Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
2023 · Shaji K. Kumar, Natalie S. Callander, et al. · Journal of the National Comprehensive Cancer Network · 163
PDF
NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025
2025 · Shaji K. Kumar, Natalie S. Callander, et al. · Journal of the National Comprehensive Cancer Network · 55
PDF
Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
2023 · Shaji K Kumar, Natalie S Callander, et al. · PubMed · 44
Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
2024 · Shaji K. Kumar, Natalie S. Callander, et al. · Journal of the National Comprehensive Cancer Network · 35
PDF
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology
2026 · Shaji K. Kumar, Natalie S. Callander, et al. · Journal of the National Comprehensive Cancer Network · 24
POSTER: CT-654 From Response Rates to Toxicity Profiles: A Meta-Analysis of Two FDA Approved CAR-T Therapies in Relapsed/Refractory Multiple Myeloma—2025
2025 · Prakhyath Srikaram, Sai Nithin Avvaru, et al. · Clinical Lymphoma Myeloma & Leukemia
CT-654: From Response Rates to Toxicity Profiles: A Meta-Analysis of Two FDA Approved CAR-T Therapies in Relapsed/Refractory Multiple Myeloma—2025
2025 · Prakhyath Srikaram, Sai Nithin Avvaru, et al. · Clinical Lymphoma Myeloma & Leukemia
Comprehensive Analysis of Structural and Social Determinants of Health Leading to Delays in Seeking Hematologic Care: Survey of an Underserved Population with Hematologic Malignancies
2023 · Laura Quillen, Noura Elsedawy, et al. · Blood
Works count: 9
Citation count: 528
H-index: 6
I10-index: 6
Year
Topic
Type